CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Global Encephalitis Vaccination Competitive Landscape Professional Research Report 2024
... caused by viral infections. There are different types of encephalitis, often associated with specific viruses, such as Japanese encephalitis, tick-borne encephalitis, or West Nile virus. Vaccines are available for some of these viral strains and ... Read More
-
Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Global Forecast 2024-2030
... at USD 6.98 billion in 2023 and expected to reach USD 7.32 billion in 2024, at a CAGR 5.06% to reach USD 9.87 billion by 2030. Transdermal drug delivery comprises the production, distribution, and application ... Read More
-
Cytomegalovirus Treatment Market by Diseases (Encephalitis, Gastrointestinal Ulcers, Pneumonia), Drug (Cidofovir, Foscarnet, Ganciclovir), Distribution Channel, Application - Global Forecast 2024-2030
... to reach USD 576.99 million in 2024, at a CAGR 7.67% to reach USD 903.39 million by 2030. The cytomegalovirus (CMV) treatment includes all aspects of medical practices to manage and treat cytomegalovirus infections, a ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030. Cell and gene therapy manufacturing ... Read More
-
Esoteric Testing Market Size, Share & Trends by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029
... global esoteric testing market is valued at an estimated USD 32.2 billion in 2024 and is projected to reach USD 48.3 billion by 2029, at a CAGR of 8.5% during the forecast period. Growth in ... Read More
-
Global Electroceutical Bioelectric Medicine Market 2024-2028
... electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Amyotrophic Lateral Sclerosis- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Attention-deficit/hyperactivity disorder (ADHD) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Attention-deficit/hyperactivity disorder (ADHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Attention-deficit/hyperactivity disorder (ADHD) market report provides current ... Read More
-
Diffuse Intrinsic Pontine Glioma (DIPG) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Diffuse Intrinsic Pontine Glioma (DIPG), historical and forecasted epidemiology as well as the Diffuse Intrinsic Pontine Glioma (DIPG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Lou Gehrig's disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Lou Gehrig's disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Lou Gehrig's disease market report provides current ... Read More
-
Opioid Dependence – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Opioid Dependence market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Opioid Dependence market report provides current treatment practices, emerging drugs, Opioid ... Read More
-
Panic Disorder – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Panic Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Panic Disorder market report provides current treatment practices, emerging drugs, Panic ... Read More
-
Gene Therapy In CNS Disorder – Market Insight, Epidemiology, and Market Forecast – 2034
... the Gene Therapy In CNS Disorder, historical and forecasted epidemiology as well as the Gene Therapy In CNS Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Delirium – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Delirium market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Delirium market report provides current treatment practices, emerging drugs, Delirium market share of the individual ... Read More
-
Dementia with Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Dementia with Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dementia with Diabetes market report provides current ... Read More
-
Fibromyalgia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Fibromyalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Fibromyalgia market report provides current treatment practices, emerging drugs, Fibromyalgia market share of the individual ... Read More
-
Gliosarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Gliosarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gliosarcoma market report provides current treatment practices, emerging drugs, Gliosarcoma market share of the individual ... Read More
-
Cluster Headache – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Cluster Headache market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cluster Headache market report provides current treatment practices, emerging drugs, Cluster ... Read More
-
Social Anxiety Disorder (SAD) – Market Insight, Epidemiology, and Market Forecast – 2034
... Anxiety Disorder (SAD), historical and forecasted epidemiology as well as the Social Anxiety Disorder (SAD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Social Anxiety Disorder ... Read More
-
Central Nervous System Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
... Nervous System Lymphoma, historical and forecasted epidemiology as well as the Central Nervous System Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Central Nervous System ... Read More
-
Motor Neuron Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Motor Neuron Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Motor Neuron Disease market report provides current ... Read More
-
Schizoaffective Disorder – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Schizoaffective Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Schizoaffective Disorder market report provides current treatment practices, emerging drugs, Schizoaffective ... Read More
-
Gene and Cell Therapies Targeting CNS Disorders – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Gene and Cell Therapies Targeting CNS Disorders, historical and forecasted epidemiology as well as the Gene and Cell Therapies Targeting CNS Disorders market trends in the United States, EU5 (Germany, ... Read More
-
Autism Spectrum Disorder – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Autism Spectrum Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autism Spectrum Disorder market report provides current ... Read More
-
Global Active Pharmaceutical Ingredients (API) Market Report by Drug Type (Innovative, Generic), Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Application (Cardiovascular Diseases, Oncology, Central Nervous System and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Applications), Regions and Company Analysis 2024-2032
... Other Applications), Regions and Company Analysis 2024-2032 Active Pharmaceutical Ingredients Market is envisioned at US$ 212.12 billion in 2023 and is anticipated to attain US$ 377.05 billion via 2032, growing at a CAGR of % ... Read More
Research Assistance
